This article reviews the use of modafinil in palliative care, and its use in promoting vigilance and wakefulness. Modafinil’s therapeutic and chemical class, mechanism of action, pharmacokinetics, indications, dosage, side effects, and drug interactions are also discussed. Modafinil seems to fit the requirements of portmanteau, using one drug to treat multiple symptoms.
McClellan KJ, Spencer CM: Modafinil: A review of its pharmacology and clinical efficacy in the management of narcolepsy. CNS Drugs. 1998; 9: 311-324.
2.
US Modafinil in Narcolepsy Multicenter Study Group: Randomized trial of modafinil as a treatment for the excessive daytime somnolence of narcolepsy. Neurology. 2000; 54: 1166-1175.
3.
Wisor JP, Nishino S, Sora I, et al.: Dopaminergic role in stimulant-induced wakefulness. J Neuroscience. 2001; 21(5): 1787-1794.
4.
Lin JS, Hou Y, Jouvet M: Potential brain neuronal targets for amphetamine-, methylphenidate-, and modafinil-induced wakefulness, evidenced by c-fos immunocytochemistry in the cat. Proc National Academy of Science (USA). 1996; 93: 14128-14133.
5.
Wong YN, King SP, Simcoe D, et al.: Open-label, single-dose pharmacokinetic study of modafinil tablets: Influence of age and gender in normal subjects. J Clinical Pharmacology. 1999; 39(3): 281-288.
6.
Wong YN, Simcoe D, Hartman LN, et al.: A double-blind, placebo-controlled, ascending-dose evaluation of the pharmacokinetics and tolerability of modafinil tablets in healthy male volunteers. J Clinical Pharmacology. 1999; 39(1): 30-40.
7.
Cochran JW: Effect of modafinil on fatigue associated with neurological illnesses. J Chronic Fatigue Syndrome. 2001; 8(2): 65-70.
8.
Menza MA, Kaufman KR, Castellanos A: Modafinil augmentation of antidepressant treatment in depression. J Clinical Psychiatry. 2000; 61: 378-381.
9.
Portenoy RK, Itri LA: Cancer-related fatigue: Guidelines for evaluation and management. The Oncologist. 1999; 4: 1-10.
10.
Kim HF, Braun U, Kunik ME: Anxiety and depression in medically ill older adults. J Clinical Geropsychology. 2001; 7(2): 117-130.
11.
Twycross R: Symptom Management in Advanced Cancer. Oxford, Radcliffe Medical Press, 1997.
12.
McKevoy KG (ed.): American Hospital Formulary Service Drug Information. Bethesda, MD: American Society of Health-System Pharmacists, 2001.
13.
Davis MP, Dickerson ED, Pappagallo M, et al.: Mirtazapine: Heir apparent to amitriptyline?American J Hospice & Palliative Care. 2001; 18(1): 42-46.
